38 rules, proposed rules and notices published in the Federal Register since January 2025 name the 340B program. Here is what each one does about 340B, the day comments close, the day it takes effect, and where to read it.
Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Covered entities' first required Part D 340B claim data, for January to June 2027, is due
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
91 FR 48883Notice Regarding 340B Rebate Model Pilot Program
Opens a revised 340B Rebate Model Pilot Program. From January 1, 2027, drug makers with an approved plan may give the 340B price as a rebate after the sale, not as a discount up front, on the drugs selected for Medicare price negotiation for 2026 and 2027.
Agency
Health Resources and Services Administration
Published
3 August 2026
Takes effect
1 January 2027
Other days it sets
Drug makers' plans for the rebate pilot were due
The day by which the agency said it would approve drug makers' plans for the rebate pilot, if any
The day by which the agency says it will publish its evaluation of the rebate pilot's first year
91 FR 37121340B Rebate Model Pilot Program Application, Implementation, and Evaluation, Correction
Corrects the June 15, 2026 notice on the rebate pilot's data collection. The total number of responses changes from 793,080 to 793,091 to include the 11 drug maker plan submissions.
91 FR 35989Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW
Says the rebate pilot's data collection was sent to the Office of Management and Budget for approval, and opens 30 days for comments. It answers the comments on burden made on the earlier 60-day notice.
91 FR 9632Request for Information: 340B Rebate Model Pilot Program Extension
Extends the comment period on the February 17, 2026 request for information about a 340B rebate pilot from 30 days to 60 days, so that comments are due April 20, 2026.
91 FR 9632Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW
Asks for comments on a new data collection for a possible 340B rebate pilot: drug makers' plans, their monthly reports, and claim data from covered entities. It replaces an emergency-cleared collection that the agency ended.
91 FR 7287Request for Information: 340B Rebate Model Pilot Program
Asks the public whether the agency should use a rebate model for 340B and how to run one, including costs, payment timing, denials, data and duplicate discounts. It says the 2025 pilot was paused after a court order of December 29, 2025.
91 FR 714Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program, OMB No. 0915-0327-Revision
Sends a revision of the 340B enrollment and recertification forms to the Office of Management and Budget. New items are collected: grant papers from sexually transmitted disease and tuberculosis grantees, the Title X assistance period, and the Tribal agreement number.
90 FR 44197Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-0111-Extension
Asks for comments, over 60 days, on continuing the 2025 rebate pilot's data collection: drug makers' plans, monthly reports, and the claim data covered entities send to ask for rebates. It says emergency clearance was given on August 26, 2025.
90 FR 38165340B Program Notice: Application Process for the 340B Rebate Model Pilot Program; Correction
Republishes, as a correction, the August 1, 2025 notice that opened the first 340B rebate pilot. It moves the comment deadline to September 8, 2025 and fills in the docket number. A court set that pilot aside on February 10, 2026.
90 FR 38167Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program, OMB No. 0915-0327-Revision
Proposes revising the 340B enrollment and recertification forms, and takes comments until October 6, 2025. New items would be collected: grant papers from sexually transmitted disease and tuberculosis grantees, the Title X assistance period, and the Tribal agreement number.
90 FR 36163340B Program Notice: Application Process for the 340B Rebate Model Pilot Program
Opens the first 340B rebate pilot. Drug makers with Medicare negotiation agreements for 2026 could apply to pay rebates, not discounts up front, on selected drugs from January 1, 2026. A court set this notice aside on February 10, 2026.
90 FR 3881Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; 340B Drug Pricing Program; Initiation of the Administrative Dispute Resolution Process
Sends a data collection to the Office of Management and Budget for the papers a covered entity or drug maker files to start a 340B Administrative Dispute Resolution claim, with 30 days for comments.
91 FR 70992Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Requires 340B covered entities to report Medicare Part D 340B claim data every quarter to a 340B repository run by the Centers for Medicare & Medicaid Services, for claims from January 1, 2027. The first required submission is due September 30, 2027.
Agency
Centers for Medicare & Medicaid Services
Published
9 November 2026
Takes effect
1 January 2027
Docket
CMS-1848-F
Other days it sets
Covered entities' first required Part D 340B claim data, for January to June 2027, is due
Where it names 340B: 91 FR 70992
… data are unavailable and the calculation of the Part D rebate amount in such instances; modifies the methodology finalized in the CY 2026 PFS final rule to account for 340B-eligible units for AIDS Drug Assistance Program (ADAP) clients for the applicable period beginning October 1, 2025; and requires Medicare providers and suppliers that …
From the document’s text. It names 340B 800 times.
91 FR 70284Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Sets Medicare hospital outpatient payment for drugs bought under 340B at average sales price minus 28 percent for 2027, where minus 33.4 percent had been proposed. Rural sole community hospitals, children's hospitals and the cancer hospitals paid outside the prospective payment system are exempt. Payments for other services at hospitals subject to the 340B remedy offset are reduced by 2.0 percentage points.
Agency
Centers for Medicare & Medicaid Services
Published
6 November 2026
Comments close
4 January 2027
Takes effect
1 January 2027
Docket
CMS-1850-FC
Where it names 340B: 91 FR 70284
… outpatient quality reporting requirements by applying a reporting factor of 0.9804 to the OPPS payments and copayments for all applicable services. Under the final 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 2.0 percentage points. ASC Payment Update: For CYs 2019 through …
From the document’s text. It names 340B 841 times.
91 FR 66408Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
Would require pharmacy benefit managers' reports to Medicare Part D plans to include a list of the covered drugs that are subject to a 340B agreement with a covered entity, where the manager or an affiliate has a contract or other arrangement with that entity.
Agency
Centers for Medicare & Medicaid Services
Published
20 October 2026
Comments close
15 December 2026
Docket
CMS-4214-P
Where it names 340B: 91 FR 66408
… supply chain--including pharmacy spread pricing, retention of a portion of the rebate negotiated with the pharmaceutical manufacturer, and increasing ownership of 340B contract pharmacies--is often not transparent to health plans and may contribute to high drug prices.\13\ Because PBM compensation is often linked to the price of the …
91 FR 62936Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Sets up the GLOBE Model, a Medicare Part B drug rebate test, and leaves 340B units out of its rebate count. It keeps the existing 340B claims modifier, TB, to find those units and says 340B itself, including how its price is calculated, is outside the model.
Agency
Centers for Medicare & Medicaid Services
Published
2 October 2026
Takes effect
30 November 2026
Docket
CMS-5545-F
Other days it sets
The GLOBE Model begins, with drug makers' voluntary price data
The GLOBE Model's first performance year begins
Where it names 340B: 91 FR 62936
… and may be more likely to experience shortages. Several commenters stated that the Negotiation Program, the Working Families Tax Cuts Act (Pub. L. 119-21), and the 340B Drug Pricing Program (section 340B of the Public Health Services Act) include provisions for orphan drug exclusions and that the 2020 Most Favored Nation (MFN) Model …
91 FR 60568Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards
One question in this request for information is about 340B: it asks what standard Medicare Part D pharmacy contract terms say about dispensing to 340B patients, and how plan sponsors decide that a claim is for a 340B patient.
Agency
Centers for Medicare & Medicaid Services
Published
24 September 2026
Comments close
23 November 2026
Docket
CMS-4217-NC
Where it names 340B: 91 FR 60568
… (AI) with respect to Part D pharmacy reimbursement; Information on standard Part D pharmacy contract terms and conditions relating to dispensing covered Part D drugs to 340B patients enrolled in Part D, including whether such 340B specific terms and conditions are common, and whether and how Part D plan sponsors determine when a claim is …
91 FR 43842Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Would require 340B covered entities to report Medicare Part D 340B claim data every quarter to a 340B repository run by the Centers for Medicare & Medicaid Services, for claims from January 1, 2027. Reporting was voluntary when this was proposed. Made final at 91 FR 70992.
Agency
Centers for Medicare & Medicaid Services
Published
16 July 2026
Comments closed
14 September 2026
Docket
CMS-1848-P
Where it names 340B: 91 FR 43842
… and the calculation of the Part D rebate amount in such instances; proposes a modification to the methodology finalized in the CY 2026 PFS final rule to account for 340B-eligible units for AIDS Drug Assistance Program (ADAP) enrollees for the applicable period beginning October 1, 2025; and proposes to require Medicare providers and …
From the document’s text. It names 340B 290 times.
91 FR 41734Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
Would pay hospitals for drugs bought under 340B at average sales price minus 33.4 percent for 2027, with minus 28 percent as an alternative, would exempt rural sole community hospitals, children's hospitals and the cancer hospitals paid outside the prospective payment system, would have hospitals mark 340B drugs with the claim modifier JG, and would raise the 340B remedy offset on other payments from 0.5 percent to 3 percent.
Agency
Centers for Medicare & Medicaid Services
Published
7 July 2026
Comments closed
31 August 2026
Docket
CMS-1850-P
Where it names 340B: 91 FR 41734
… outpatient quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. Under the proposed 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 3 percentage points. ASC Payment Update: For CYs 2019 through …
From the document’s text. It names 340B 413 times.
Raises the penalty for each instance of overcharging a 340B covered entity from $7,034 to $7,217, as one row in the yearly inflation adjustment of the Department of Health and Human Services' civil penalties.
Agency
Health and Human Services Department
Published
28 January 2026
Where it names 340B: 91 FR 3665
… or conceals any record or report required. 56b(d)(1)(B)(vi).......... ...................... HRSA.......... Penalty for each instance of overcharging 2024 7,034 7,217 a 340B covered entity. 299c-3(d)................. ...................... AHRQ.......... Penalty for using or disclosing 2024 18,291 18,766 identifiable information obtained in …
90 FR 60338Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
Would set up the GUARD Model, a Medicare Part D drug rebate test, and would leave out drug units covered under 340B. It says the agency cannot yet tell 340B claims apart in Part D data, so it assumed that 10 percent of units were 340B.
Agency
Centers for Medicare & Medicaid Services
Published
23 December 2025
Comments closed
23 February 2026
Docket
CMS-5546-P
Where it names 340B: 90 FR 60338
… We propose at Sec. 514.125(b) that the following drug units would be excluded from the GUARD Model: drug units for which payment is subject to an agreement under 340B. C. Proposed Model Test Design, Geographic Selection, and Beneficiary Population Section 1115A(b) of the Act gives the Secretary discretion in the design of models, …
90 FR 60244Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Would set up the GLOBE Model, a Medicare Part B drug rebate test, and would leave out units on claims billed with a 340B modifier. Made final at 91 FR 62936.
Agency
Centers for Medicare & Medicaid Services
Published
23 December 2025
Comments closed
23 February 2026
Docket
CMS-5545-P
Where it names 340B: 90 FR 60244
… applicable calendar quarter. This approach would ensure that units that are not included in the total number of billing units determined under 42 CFR 427.303, such as 340B units and units of discarded drugs, would also not be included in the total number of GLOBE Model billing units. We note that, because the total number of GLOBE Model …
90 FR 53448Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Rating; Hospital Price Transparency; and Notice of Closure of a Teaching Hospital and Opportunity To Apply for Available Slots
Keeps the 340B remedy offset on other hospital outpatient payments at 0.5 percent for 2026, where 2 percent had been proposed, and says a survey of what hospitals pay for drugs will open by early 2026.
Agency
Office of the Secretary
Published
25 November 2025
Comments closed
20 January 2026
Took effect
1 January 2026
Docket
CMS-1834-FC
Where it names 340B: 90 FR 53448
… quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. We note that under the final 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 0.5 percentage points. ASC Payment Update: For CYs 2019 through …
From the document’s text. It names 340B 270 times.
90 FR 49266Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Sets how Medicare removes Part D 340B units from drug inflation rebates starting January 1, 2026, and opens a voluntary 340B repository where covered entities may submit claim data.
Agency
Centers for Medicare & Medicaid Services
Published
5 November 2025
Took effect
1 January 2026
Docket
CMS-1832-F
Where it names 340B: 90 FR 49266
… Drug Inflation Rebate Program, this rule finalizes a methodology for removal of units for a Part D rebatable drug for which a manufacturer provides a discount under the 340B Program for the applicable period beginning October 1, 2025, as well as the establishment of a voluntary 340B data repository for Part D claims for testing purposes. …
From the document’s text. It names 340B 639 times.
90 FR 33476Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Ratings; and Hospital Price Transparency
Would raise the 340B remedy offset on other hospital outpatient payments from 0.5 percent to 2 percent for 2026, and announces a survey of what hospitals pay for drugs.
Agency
Office of the Secretary
Published
17 July 2025
Comments closed
15 September 2025
Docket
CMS-1834-P
Where it names 340B: 90 FR 33476
… quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. We note that under the proposed 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 2.0 percentage points. ASC Payment Update: For CYs 2019 through …
From the document’s text. It names 340B 113 times.
90 FR 32352Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Would remove Part D 340B units from Medicare drug inflation rebates starting January 1, 2026, by matching claims, and would set up a voluntary 340B repository for covered entities' claim data.
Agency
Centers for Medicare & Medicaid Services
Published
16 July 2025
Comments closed
12 September 2025
Docket
CMS-1832-P
Where it names 340B: 90 FR 32352
… of a Part D rebate amount, and proposes a methodology for removal of units for a Part D rebatable drug for which a manufacturer provides a discount under the 340B Program, as well as the establishment of a 340B data repository for Part D claims. This rulemaking proposes to modify policies for the Shared Savings Program, which is …
From the document’s text. It names 340B 260 times.
90 FR 16441Lowering Drug Prices by Once Again Putting Americans First
Executive Order 14273. Section 7 tells the Secretary of Health and Human Services to make future health center grants depend on offering insulin and injectable epinephrine to certain low-income patients at or below the price the health center paid under 340B, plus a minimal administration fee.
Agency
Executive Office of the President
Published
18 April 2025
Where it names 340B: 90 FR 16441
… establishing practices to make insulin and injectable epinephrine available at or below the discounted price paid by the health center grantee or sub-grantee under the 340B Prescription Drug Program (plus a minimal administration fee) to individuals with low incomes, as determined by the Secretary, who: (a) have a high cost-sharing …
The Federal Register is the authority. The sentence on each document is ours, written after reading it, and covers only what it does about 340B. Titles, agencies and dates are the Federal Register’s own. Read the document before you rely on it.